Autophagy Modulation in Lymphocytes From COVID-19 Patients: New Therapeutic Target in SARS-COV-2 Infection
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the novel coronavirus, causing coronavirus disease 2019 (COVID-19). During virus infection, several pro-inflammatory cytokines are produced, leading to the "cytokine storm." Among these, interleukin (IL)-6, tumor necrosis fact...
Saved in:
Main Authors: | Marta Vomero (Author), Cristiana Barbati (Author), Tania Colasanti (Author), Alessandra Ida Celia (Author), Mariangela Speziali (Author), Federica Maria Ucci (Author), Claudia Ciancarella (Author), Fabrizio Conti (Author), Cristiano Alessandri (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tofacitinib Decreases Autophagy of Fibroblast-Like Synoviocytes From Rheumatoid Arthritis Patients
by: M. Vomero, et al.
Published: (2022) -
Are Tattoos Safe in Patients With Systemic Lupus Erythematosus? Results From a Single-Center Study
by: Francesco Natalucci, et al.
Published: (2024) -
Liver Involvement in SARS-CoV-2 Vertically Infected Newborn: A Case Report
by: Ilaria Stolfi, et al.
Published: (2021) -
How Tumor Cells Choose Between Epithelial-Mesenchymal Transition and Autophagy to Resist Stress-Therapeutic Implications
by: Fabrizio Marcucci, et al.
Published: (2018) -
An overview on viral interference during SARS-CoV-2 pandemic
by: Luigi Matera, et al.
Published: (2023)